Derivation Web

v0.1 · api

Chain for claim_af2e390947b74ecd

8 nodes. Root first; inputs below.

depth 0 · claim · via classify
claim_af2e390947b74ecd
**Selected angle:** `source`

## One-sentence thesis

The cited direct receipts support a bounded working claim: 55.8% vs 13.2%, respectively; P < .001; Gastrointestinal events were reported in 49.1% of participants who continued subcutaneous semaglutide vs 26.1% with placebo.

**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-deriv…
sha256 d9d4c382b551578f…
depth 1 · source
source_3b4a0e0a9df14eb2
**Selected angle:** `source`

## One-sentence thesis

The cited direct receipts support a bounded working claim: 55.8% vs 13.2%, respectively; P < .001; Gastrointestinal events were reported in 49.1% of participants who continued subcutaneous semaglutide vs 26.1% with placebo.


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-deri…
sha256 f7a3e6f59ea73e8b…
depth 1 · source
source_613e1dbce7c54432
{"publication_id": "739db6c3-bcfd-4b6c-acc0-6f2a3ee0c136", "traces": [{"candidate_sources": [{"doi": null, "study": "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial", "url": null}, {"doi": null, "study": "Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo…
sha256 569c38ba22401a38…
depth 1 · source
source_100a05eff1f046a9
{"content_hash": null, "edges": [{"from": "739db6c3-bcfd-4b6c-acc0-6f2a3ee0c136", "to": "claim_1", "type": "contains_claim"}, {"from": "739db6c3-bcfd-4b6c-acc0-6f2a3ee0c136", "to": "claim_2", "type": "contains_claim"}, {"from": "739db6c3-bcfd-4b6c-acc0-6f2a3ee0c136", "to": "claim_3", "type": "contains_claim"}, {"from": "739db6c3-bcfd-4b6c-acc0-6f2a3ee0c136", "to": "claim_4", "type": "contains_clai…
sha256 c9d1ba8373b35135…
depth 1 · source
source_e981535381464d07
{"contradictions": ["_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._"], "limitations": ["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty f…
sha256 205fecb6cf4fd928…
depth 1 · source
source_3bab51ce15a54e63
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
Effect of Cont…
sha256 f50b4130ea3ece32…
depth 1 · source
source_45d87ef54b2c46ae
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "739db6c3-bcfd-4b6c-acc0-6f2a3ee0c136", "sources": [{"directness": "primary", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Th…
sha256 11229dc174247024…
depth 1 · source
source_a30251f016e24834
{"decision": "accept", "gate_failures": [], "notes": ["accepted and queued for publish"], "review_recommendation": "accept"}
sha256 0b5aafa0279505ed…